Voloridge Investment Management
ADMA icon

Voloridge Investment Management’s ADMA Biologics ADMA Stock Holding History

Voloridge Investment Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-296,463
Closed -$2.67M – 790
2026
Q1 		$2.67M Sell
296,463
-726,787
-71% -$11.5M 0.01% 786
2025
Q4 		$18.7M Buy
+1,023,250
New +$17.2M 0.07% 383
2024
Q4 		– Sell
-218,059
Closed -$4.36M – 1152
2024
Q3 		$4.36M Sell
218,059
-1,595,761
-88% -$24.8M 0.02% 809
2024
Q2 		$20.3M Buy
1,813,820
+135,263
+8% +$1.13M 0.08% 361
2024
Q1 		$11.1M Buy
+1,678,557
New +$9.17M 0.04% 468

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Voloridge Investment Management's ADMA Position: Q2 2026 in Review

Voloridge Investment Management sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 296,463 shares — an estimated $2.67M sold.

Voloridge Investment Management first reported a position in ADMA in Q1 2024 and held it in 5 quarters. The position peaked at $20.3M in Q2 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Voloridge Investment Management reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 296,463 ADMA Biologics shares in Q2 2026, an estimated $2.67M.
  • Voloridge Investment Management first reported a position in ADMA Biologics in Q1 2024 and held it in 5 quarters.
  • Voloridge Investment Management's ADMA Biologics position peaked at $20.3M in Q2 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.